APO Research
Talk to an analyst

APO RESEARCH · REPORT

Serum and Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Serum and Plasma Proteomics Service Industry Growth and Trends Forecast to 2032

12 August 2026120 pages

Choose your research edition.

Industry ResearchSerum and Plasma Proteomics Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Serum and Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Serum and Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Serum and Plasma Proteomics Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Serum and Plasma Proteomics Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Serum and Plasma Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Serum and Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Serum and Plasma Proteomics Service market include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Serum and Plasma Proteomics Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Serum and Plasma Proteomics Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Serum and Plasma Proteomics Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Serum and Plasma Proteomics Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Serum and Plasma Proteomics Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Serum and Plasma Proteomics Service Market by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Serum and Plasma Proteomics Service Segment by Type

Plasma Proteomics Analysis Service

Serum Proteomics Analysis Service

Serum and Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Serum and Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum and Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Serum and Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum and Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Serum and Plasma Proteomics Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Serum and Plasma Proteomics Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Serum and Plasma Proteomics Service Market Share by Region (2021-2026) Table 4. Global Serum and Plasma Proteomics Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Serum and Plasma Proteomics Service Market Share by Region (2027-2032) Table 6. Global Serum and Plasma Proteomics Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Serum and Plasma Proteomics Service Market Size Share by Type (2021-2026) Table 9. Global Serum and Plasma Proteomics Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Serum and Plasma Proteomics Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Serum and Plasma Proteomics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Serum and Plasma Proteomics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Serum and Plasma Proteomics Service Market Size Share by Application (2021-2026) Table 24. Global Serum and Plasma Proteomics Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Serum and Plasma Proteomics Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Serum and Plasma Proteomics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Serum and Plasma Proteomics Service Industry Trends Table 37. Serum and Plasma Proteomics Service Industry Drivers Table 38. Serum and Plasma Proteomics Service Industry Opportunities and Challenges Table 39. Serum and Plasma Proteomics Service Industry Restraints Table 40. Global Serum and Plasma Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Serum and Plasma Proteomics Service Revenue Market Share by Company (2021-2026) Table 42. Global Serum and Plasma Proteomics Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Serum and Plasma Proteomics Service Key Company Headquarters & Area Served Table 44. Global Serum and Plasma Proteomics Service Company, Product Type & Application Table 45. Global Serum and Plasma Proteomics Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Serum and Plasma Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BostonGene Company Information Table 49. BostonGene Business Overview Table 50. BostonGene Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BostonGene Serum and Plasma Proteomics Service Product Portfolio Table 52. BostonGene Recent Development Table 53. CellCarta Company Information Table 54. CellCarta Business Overview Table 55. CellCarta Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CellCarta Serum and Plasma Proteomics Service Product Portfolio Table 57. CellCarta Recent Development Table 58. GENEWIZ (Azenta Life Sciences) Company Information Table 59. GENEWIZ (Azenta Life Sciences) Business Overview Table 60. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio Table 62. GENEWIZ (Azenta Life Sciences) Recent Development Table 63. CDI Labs Company Information Table 64. CDI Labs Business Overview Table 65. CDI Labs Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. CDI Labs Serum and Plasma Proteomics Service Product Portfolio Table 67. CDI Labs Recent Development Table 68. Biognosys Company Information Table 69. Biognosys Business Overview Table 70. Biognosys Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biognosys Serum and Plasma Proteomics Service Product Portfolio Table 72. Biognosys Recent Development Table 73. Discovery Life Sciences Company Information Table 74. Discovery Life Sciences Business Overview Table 75. Discovery Life Sciences Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio Table 77. Discovery Life Sciences Recent Development Table 78. Firalis Molecular Precision Company Information Table 79. Firalis Molecular Precision Business Overview Table 80. Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio Table 82. Firalis Molecular Precision Recent Development Table 83. Cell Signaling Technology (CST) Company Information Table 84. Cell Signaling Technology (CST) Business Overview Table 85. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio Table 87. Cell Signaling Technology (CST) Recent Development Table 88. Sampled (Infinity Biologix) Company Information Table 89. Sampled (Infinity Biologix) Business Overview Table 90. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio Table 92. Sampled (Infinity Biologix) Recent Development Table 93. APTBIO Company Information Table 94. APTBIO Business Overview Table 95. APTBIO Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. APTBIO Serum and Plasma Proteomics Service Product Portfolio Table 97. APTBIO Recent Development Table 98. Sinotech Genomics Company Information Table 99. Sinotech Genomics Business Overview Table 100. Sinotech Genomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio Table 102. Sinotech Genomics Recent Development Table 103. Biodesix Company Information Table 104. Biodesix Business Overview Table 105. Biodesix Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Biodesix Serum and Plasma Proteomics Service Product Portfolio Table 107. Biodesix Recent Development Table 108. Panome Bio Company Information Table 109. Panome Bio Business Overview Table 110. Panome Bio Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Panome Bio Serum and Plasma Proteomics Service Product Portfolio Table 112. Panome Bio Recent Development Table 113. Novogene Company Information Table 114. Novogene Business Overview Table 115. Novogene Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Novogene Serum and Plasma Proteomics Service Product Portfolio Table 117. Novogene Recent Development Table 118. PTM BIO Company Information Table 119. PTM BIO Business Overview Table 120. PTM BIO Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. PTM BIO Serum and Plasma Proteomics Service Product Portfolio Table 122. PTM BIO Recent Development Table 123. BGI Genomics Company Information Table 124. BGI Genomics Business Overview Table 125. BGI Genomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BGI Genomics Serum and Plasma Proteomics Service Product Portfolio Table 127. BGI Genomics Recent Development Table 128. Evotec Company Information Table 129. Evotec Business Overview Table 130. Evotec Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Evotec Serum and Plasma Proteomics Service Product Portfolio Table 132. Evotec Recent Development Table 133. Metware Biotechnology Company Information Table 134. Metware Biotechnology Business Overview Table 135. Metware Biotechnology Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio Table 137. Metware Biotechnology Recent Development Table 138. MRM Proteomics Company Information Table 139. MRM Proteomics Business Overview Table 140. MRM Proteomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 142. MRM Proteomics Recent Development Table 143. Lc-Bio Technologies Company Information Table 144. Lc-Bio Technologies Business Overview Table 145. Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio Table 147. Lc-Bio Technologies Recent Development Table 148. Eurofins Scientific Company Information Table 149. Eurofins Scientific Business Overview Table 150. Eurofins Scientific Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio Table 152. Eurofins Scientific Recent Development Table 153. MtoZ-Biolabs Company Information Table 154. MtoZ-Biolabs Business Overview Table 155. MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio Table 157. MtoZ-Biolabs Recent Development Table 158. Creative Proteomics Company Information Table 159. Creative Proteomics Business Overview Table 160. Creative Proteomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio Table 162. Creative Proteomics Recent Development Table 163. Macrogen Company Information Table 164. Macrogen Business Overview Table 165. Macrogen Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Macrogen Serum and Plasma Proteomics Service Product Portfolio Table 167. Macrogen Recent Development Table 168. TATAA Biocenter Company Information Table 169. TATAA Biocenter Business Overview Table 170. TATAA Biocenter Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio Table 172. TATAA Biocenter Recent Development Table 173. OmicScouts (Momentum Biotechnologies) Company Information Table 174. OmicScouts (Momentum Biotechnologies) Business Overview Table 175. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio Table 177. OmicScouts (Momentum Biotechnologies) Recent Development Table 178. Precision Biomarker Laboratories (PBL) Company Information Table 179. Precision Biomarker Laboratories (PBL) Business Overview Table 180. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio Table 182. Precision Biomarker Laboratories (PBL) Recent Development Table 183. Shanghai OE Biotech Company Information Table 184. Shanghai OE Biotech Business Overview Table 185. Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio Table 187. Shanghai OE Biotech Recent Development Table 188. RxCelerate Company Information Table 189. RxCelerate Business Overview Table 190. RxCelerate Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. RxCelerate Serum and Plasma Proteomics Service Product Portfolio Table 192. RxCelerate Recent Development Table 193. Proteomics International Company Information Table 194. Proteomics International Business Overview Table 195. Proteomics International Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. Proteomics International Serum and Plasma Proteomics Service Product Portfolio Table 197. Proteomics International Recent Development Table 198. Proteome Sciences Company Information Table 199. Proteome Sciences Business Overview Table 200. Proteome Sciences Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 201. Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio Table 202. Proteome Sciences Recent Development Table 203. Westlake Omics Company Information Table 204. Westlake Omics Business Overview Table 205. Westlake Omics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 206. Westlake Omics Serum and Plasma Proteomics Service Product Portfolio Table 207. Westlake Omics Recent Development Table 208. Crown Bioscience Company Information Table 209. Crown Bioscience Business Overview Table 210. Crown Bioscience Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 211. Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio Table 212. Crown Bioscience Recent Development Table 213. VProteomics Company Information Table 214. VProteomics Business Overview Table 215. VProteomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 216. VProteomics Serum and Plasma Proteomics Service Product Portfolio Table 217. VProteomics Recent Development Table 218. Shanghai Majorbio Bio-Pharm Company Information Table 219. Shanghai Majorbio Bio-Pharm Business Overview Table 220. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 221. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio Table 222. Shanghai Majorbio Bio-Pharm Recent Development Table 223. Applied Biomics Company Information Table 224. Applied Biomics Business Overview Table 225. Applied Biomics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 226. Applied Biomics Serum and Plasma Proteomics Service Product Portfolio Table 227. Applied Biomics Recent Development Table 228. Sapient Bioanalytics Company Information Table 229. Sapient Bioanalytics Business Overview Table 230. Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 231. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio Table 232. Sapient Bioanalytics Recent Development Table 233. Allumiqs Company Information Table 234. Allumiqs Business Overview Table 235. Allumiqs Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 236. Allumiqs Serum and Plasma Proteomics Service Product Portfolio Table 237. Allumiqs Recent Development Table 238. MS Bioworks Company Information Table 239. MS Bioworks Business Overview Table 240. MS Bioworks Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 241. MS Bioworks Serum and Plasma Proteomics Service Product Portfolio Table 242. MS Bioworks Recent Development Table 243. Shanghai Bioprofile Company Information Table 244. Shanghai Bioprofile Business Overview Table 245. Shanghai Bioprofile Serum and Plasma Proteomics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 246. Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio Table 247. Shanghai Bioprofile Recent Development Table 248. North America Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 249. North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 250. North America Serum and Plasma Proteomics Service Market Share by Country (2021-2026) Table 251. North America Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 252. North America Serum and Plasma Proteomics Service Market Share Forecast by Country (2027-2032) Table 253. Europe Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 255. Europe Serum and Plasma Proteomics Service Market Share by Country (2021-2026) Table 256. Europe Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Europe Serum and Plasma Proteomics Service Market Share Forecast by Country (2027-2032) Table 258. Asia-Pacific Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 259. Asia-Pacific Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 260. Asia-Pacific Serum and Plasma Proteomics Service Market Share by Country (2021-2026) Table 261. Asia-Pacific Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 262. Asia-Pacific Serum and Plasma Proteomics Service Market Share Forecast by Country (2027-2032) Table 263. Latin America Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 264. Latin America Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 265. Latin America Serum and Plasma Proteomics Service Market Share by Country (2021-2026) Table 266. Latin America Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 267. Latin America Serum and Plasma Proteomics Service Market Share Forecast by Country (2027-2032) Table 268. Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 269. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 270. Middle East & Africa Serum and Plasma Proteomics Service Market Share by Country (2021-2026) Table 271. Middle East & Africa Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 272. Middle East & Africa Serum and Plasma Proteomics Service Market Share Forecast by Country (2027-2032) Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Serum and Plasma Proteomics Service Product Image Figure 3. Global Serum and Plasma Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Serum and Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Serum and Plasma Proteomics Service Market Share by Region: 2025 VS 2032 Figure 6. Global Serum and Plasma Proteomics Service Market Share by Region (2021-2032) Figure 7. North America Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Plasma Proteomics Analysis Service Image Figure 13. Global Plasma Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Serum Proteomics Analysis Service Image Figure 15. Global Serum Proteomics Analysis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Serum and Plasma Proteomics Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Serum and Plasma Proteomics Service Market Share by Type 2025 VS 2032 Figure 18. North America Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032) Figure 19. Europe Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032) Figure 21. Latin America Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Serum and Plasma Proteomics Service Market Size Share by Type (2021-2032) Figure 23. Disease Biomarker Research Image Figure 24. Global Disease Biomarker Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Drug Development Image Figure 26. Global Drug Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinical Research Image Figure 28. Global Clinical Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Serum and Plasma Proteomics Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Serum and Plasma Proteomics Service Market Share by Application 2025 VS 2032 Figure 33. North America Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032) Figure 34. Europe Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032) Figure 36. Latin America Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Serum and Plasma Proteomics Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Serum and Plasma Proteomics Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Serum and Plasma Proteomics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Serum and Plasma Proteomics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 43. Europe Serum and Plasma Proteomics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Serum and Plasma Proteomics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Serum and Plasma Proteomics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Serum and Plasma Proteomics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 49. Latin America Serum and Plasma Proteomics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Serum and Plasma Proteomics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Serum and Plasma Proteomics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Serum and Plasma Proteomics Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Proteomics Analysis Service
  • Serum Proteomics Analysis Service
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Serum and Plasma Proteomics Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Serum and Plasma Proteomics Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Serum and Plasma Proteomics Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Serum and Plasma Proteomics Service Market Size (2021-2032)
  8. 1.5.1 North America Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032)
2 Serum and Plasma Proteomics Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Plasma Proteomics Analysis Service
  3. 2.1.2 Serum Proteomics Analysis Service
  4. 2.2 Global Serum and Plasma Proteomics Service Market Size by Type
  5. 2.2.1 Global Serum and Plasma Proteomics Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Serum and Plasma Proteomics Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Serum and Plasma Proteomics Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Serum and Plasma Proteomics Service Market Size by Regions
  9. 2.3.1 North America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Type (2021-2026)
3 Serum and Plasma Proteomics Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Disease Biomarker Research
  3. 3.1.2 Drug Development
  4. 3.1.3 Clinical Research
  5. 3.1.4 Others
  6. 3.2 Global Serum and Plasma Proteomics Service Market Size by Application
  7. 3.2.1 Global Serum and Plasma Proteomics Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Serum and Plasma Proteomics Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Serum and Plasma Proteomics Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Serum and Plasma Proteomics Service Market Size by Regions
  11. 3.3.1 North America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Serum and Plasma Proteomics Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Serum and Plasma Proteomics Service Industry Trends
  2. 4.2 Serum and Plasma Proteomics Service Industry Drivers
  3. 4.3 Serum and Plasma Proteomics Service Industry Opportunities and Challenges
  4. 4.4 Serum and Plasma Proteomics Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Serum and Plasma Proteomics Service Revenue (2021-2026)
  2. 5.2 Global Serum and Plasma Proteomics Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Serum and Plasma Proteomics Service Key Company Headquarters & Area Served
  4. 5.4 Global Serum and Plasma Proteomics Service Company, Product Type & Application
  5. 5.5 Global Serum and Plasma Proteomics Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Serum and Plasma Proteomics Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Serum and Plasma Proteomics Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Serum and Plasma Proteomics Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BostonGene
  2. 6.1.1 BostonGene Company Information
  3. 6.1.2 BostonGene Business Overview
  4. 6.1.3 BostonGene Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BostonGene Serum and Plasma Proteomics Service Product Portfolio
  6. 6.1.5 BostonGene Recent Developments
  7. 6.2 CellCarta
  8. 6.2.1 CellCarta Company Information
  9. 6.2.2 CellCarta Business Overview
  10. 6.2.3 CellCarta Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CellCarta Serum and Plasma Proteomics Service Product Portfolio
  12. 6.2.5 CellCarta Recent Developments
  13. 6.3 GENEWIZ (Azenta Life Sciences)
  14. 6.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 6.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 6.3.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Portfolio
  18. 6.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 6.4 CDI Labs
  20. 6.4.1 CDI Labs Company Information
  21. 6.4.2 CDI Labs Business Overview
  22. 6.4.3 CDI Labs Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 CDI Labs Serum and Plasma Proteomics Service Product Portfolio
  24. 6.4.5 CDI Labs Recent Developments
  25. 6.5 Biognosys
  26. 6.5.1 Biognosys Company Information
  27. 6.5.2 Biognosys Business Overview
  28. 6.5.3 Biognosys Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biognosys Serum and Plasma Proteomics Service Product Portfolio
  30. 6.5.5 Biognosys Recent Developments
  31. 6.6 Discovery Life Sciences
  32. 6.6.1 Discovery Life Sciences Company Information
  33. 6.6.2 Discovery Life Sciences Business Overview
  34. 6.6.3 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Discovery Life Sciences Serum and Plasma Proteomics Service Product Portfolio
  36. 6.6.5 Discovery Life Sciences Recent Developments
  37. 6.7 Firalis Molecular Precision
  38. 6.7.1 Firalis Molecular Precision Company Information
  39. 6.7.2 Firalis Molecular Precision Business Overview
  40. 6.7.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Portfolio
  42. 6.7.5 Firalis Molecular Precision Recent Developments
  43. 6.8 Cell Signaling Technology (CST)
  44. 6.8.1 Cell Signaling Technology (CST) Company Information
  45. 6.8.2 Cell Signaling Technology (CST) Business Overview
  46. 6.8.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Portfolio
  48. 6.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 6.9 Sampled (Infinity Biologix)
  50. 6.9.1 Sampled (Infinity Biologix) Company Information
  51. 6.9.2 Sampled (Infinity Biologix) Business Overview
  52. 6.9.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Portfolio
  54. 6.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 6.10 APTBIO
  56. 6.10.1 APTBIO Company Information
  57. 6.10.2 APTBIO Business Overview
  58. 6.10.3 APTBIO Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 APTBIO Serum and Plasma Proteomics Service Product Portfolio
  60. 6.10.5 APTBIO Recent Developments
  61. 6.11 Sinotech Genomics
  62. 6.11.1 Sinotech Genomics Company Information
  63. 6.11.2 Sinotech Genomics Business Overview
  64. 6.11.3 Sinotech Genomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sinotech Genomics Serum and Plasma Proteomics Service Product Portfolio
  66. 6.11.5 Sinotech Genomics Recent Developments
  67. 6.12 Biodesix
  68. 6.12.1 Biodesix Company Information
  69. 6.12.2 Biodesix Business Overview
  70. 6.12.3 Biodesix Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Biodesix Serum and Plasma Proteomics Service Product Portfolio
  72. 6.12.5 Biodesix Recent Developments
  73. 6.13 Panome Bio
  74. 6.13.1 Panome Bio Company Information
  75. 6.13.2 Panome Bio Business Overview
  76. 6.13.3 Panome Bio Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Panome Bio Serum and Plasma Proteomics Service Product Portfolio
  78. 6.13.5 Panome Bio Recent Developments
  79. 6.14 Novogene
  80. 6.14.1 Novogene Company Information
  81. 6.14.2 Novogene Business Overview
  82. 6.14.3 Novogene Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Novogene Serum and Plasma Proteomics Service Product Portfolio
  84. 6.14.5 Novogene Recent Developments
  85. 6.15 PTM BIO
  86. 6.15.1 PTM BIO Company Information
  87. 6.15.2 PTM BIO Business Overview
  88. 6.15.3 PTM BIO Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 PTM BIO Serum and Plasma Proteomics Service Product Portfolio
  90. 6.15.5 PTM BIO Recent Developments
  91. 6.16 BGI Genomics
  92. 6.16.1 BGI Genomics Company Information
  93. 6.16.2 BGI Genomics Business Overview
  94. 6.16.3 BGI Genomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BGI Genomics Serum and Plasma Proteomics Service Product Portfolio
  96. 6.16.5 BGI Genomics Recent Developments
  97. 6.17 Evotec
  98. 6.17.1 Evotec Company Information
  99. 6.17.2 Evotec Business Overview
  100. 6.17.3 Evotec Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Evotec Serum and Plasma Proteomics Service Product Portfolio
  102. 6.17.5 Evotec Recent Developments
  103. 6.18 Metware Biotechnology
  104. 6.18.1 Metware Biotechnology Company Information
  105. 6.18.2 Metware Biotechnology Business Overview
  106. 6.18.3 Metware Biotechnology Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Metware Biotechnology Serum and Plasma Proteomics Service Product Portfolio
  108. 6.18.5 Metware Biotechnology Recent Developments
  109. 6.19 MRM Proteomics
  110. 6.19.1 MRM Proteomics Company Information
  111. 6.19.2 MRM Proteomics Business Overview
  112. 6.19.3 MRM Proteomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 MRM Proteomics Serum and Plasma Proteomics Service Product Portfolio
  114. 6.19.5 MRM Proteomics Recent Developments
  115. 6.20 Lc-Bio Technologies
  116. 6.20.1 Lc-Bio Technologies Company Information
  117. 6.20.2 Lc-Bio Technologies Business Overview
  118. 6.20.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Portfolio
  120. 6.20.5 Lc-Bio Technologies Recent Developments
  121. 6.21 Eurofins Scientific
  122. 6.21.1 Eurofins Scientific Company Information
  123. 6.21.2 Eurofins Scientific Business Overview
  124. 6.21.3 Eurofins Scientific Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Eurofins Scientific Serum and Plasma Proteomics Service Product Portfolio
  126. 6.21.5 Eurofins Scientific Recent Developments
  127. 6.22 MtoZ-Biolabs
  128. 6.22.1 MtoZ-Biolabs Company Information
  129. 6.22.2 MtoZ-Biolabs Business Overview
  130. 6.22.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Portfolio
  132. 6.22.5 MtoZ-Biolabs Recent Developments
  133. 6.23 Creative Proteomics
  134. 6.23.1 Creative Proteomics Company Information
  135. 6.23.2 Creative Proteomics Business Overview
  136. 6.23.3 Creative Proteomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Creative Proteomics Serum and Plasma Proteomics Service Product Portfolio
  138. 6.23.5 Creative Proteomics Recent Developments
  139. 6.24 Macrogen
  140. 6.24.1 Macrogen Company Information
  141. 6.24.2 Macrogen Business Overview
  142. 6.24.3 Macrogen Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Macrogen Serum and Plasma Proteomics Service Product Portfolio
  144. 6.24.5 Macrogen Recent Developments
  145. 6.25 TATAA Biocenter
  146. 6.25.1 TATAA Biocenter Company Information
  147. 6.25.2 TATAA Biocenter Business Overview
  148. 6.25.3 TATAA Biocenter Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 TATAA Biocenter Serum and Plasma Proteomics Service Product Portfolio
  150. 6.25.5 TATAA Biocenter Recent Developments
  151. 6.26 OmicScouts (Momentum Biotechnologies)
  152. 6.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 6.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 6.26.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Portfolio
  156. 6.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 6.27 Precision Biomarker Laboratories (PBL)
  158. 6.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 6.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 6.27.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Portfolio
  162. 6.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 6.28 Shanghai OE Biotech
  164. 6.28.1 Shanghai OE Biotech Company Information
  165. 6.28.2 Shanghai OE Biotech Business Overview
  166. 6.28.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Portfolio
  168. 6.28.5 Shanghai OE Biotech Recent Developments
  169. 6.29 RxCelerate
  170. 6.29.1 RxCelerate Company Information
  171. 6.29.2 RxCelerate Business Overview
  172. 6.29.3 RxCelerate Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 RxCelerate Serum and Plasma Proteomics Service Product Portfolio
  174. 6.29.5 RxCelerate Recent Developments
  175. 6.30 Proteomics International
  176. 6.30.1 Proteomics International Company Information
  177. 6.30.2 Proteomics International Business Overview
  178. 6.30.3 Proteomics International Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 Proteomics International Serum and Plasma Proteomics Service Product Portfolio
  180. 6.30.5 Proteomics International Recent Developments
  181. 6.31 Proteome Sciences
  182. 6.31.1 Proteome Sciences Company Information
  183. 6.31.2 Proteome Sciences Business Overview
  184. 6.31.3 Proteome Sciences Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  185. 6.31.4 Proteome Sciences Serum and Plasma Proteomics Service Product Portfolio
  186. 6.31.5 Proteome Sciences Recent Developments
  187. 6.32 Westlake Omics
  188. 6.32.1 Westlake Omics Company Information
  189. 6.32.2 Westlake Omics Business Overview
  190. 6.32.3 Westlake Omics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  191. 6.32.4 Westlake Omics Serum and Plasma Proteomics Service Product Portfolio
  192. 6.32.5 Westlake Omics Recent Developments
  193. 6.33 Crown Bioscience
  194. 6.33.1 Crown Bioscience Company Information
  195. 6.33.2 Crown Bioscience Business Overview
  196. 6.33.3 Crown Bioscience Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  197. 6.33.4 Crown Bioscience Serum and Plasma Proteomics Service Product Portfolio
  198. 6.33.5 Crown Bioscience Recent Developments
  199. 6.34 VProteomics
  200. 6.34.1 VProteomics Company Information
  201. 6.34.2 VProteomics Business Overview
  202. 6.34.3 VProteomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  203. 6.34.4 VProteomics Serum and Plasma Proteomics Service Product Portfolio
  204. 6.34.5 VProteomics Recent Developments
  205. 6.35 Shanghai Majorbio Bio-Pharm
  206. 6.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 6.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 6.35.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  209. 6.35.4 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Portfolio
  210. 6.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 6.36 Applied Biomics
  212. 6.36.1 Applied Biomics Company Information
  213. 6.36.2 Applied Biomics Business Overview
  214. 6.36.3 Applied Biomics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  215. 6.36.4 Applied Biomics Serum and Plasma Proteomics Service Product Portfolio
  216. 6.36.5 Applied Biomics Recent Developments
  217. 6.37 Sapient Bioanalytics
  218. 6.37.1 Sapient Bioanalytics Company Information
  219. 6.37.2 Sapient Bioanalytics Business Overview
  220. 6.37.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  221. 6.37.4 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Portfolio
  222. 6.37.5 Sapient Bioanalytics Recent Developments
  223. 6.38 Allumiqs
  224. 6.38.1 Allumiqs Company Information
  225. 6.38.2 Allumiqs Business Overview
  226. 6.38.3 Allumiqs Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  227. 6.38.4 Allumiqs Serum and Plasma Proteomics Service Product Portfolio
  228. 6.38.5 Allumiqs Recent Developments
  229. 6.39 MS Bioworks
  230. 6.39.1 MS Bioworks Company Information
  231. 6.39.2 MS Bioworks Business Overview
  232. 6.39.3 MS Bioworks Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  233. 6.39.4 MS Bioworks Serum and Plasma Proteomics Service Product Portfolio
  234. 6.39.5 MS Bioworks Recent Developments
  235. 6.40 Shanghai Bioprofile
  236. 6.40.1 Shanghai Bioprofile Company Information
  237. 6.40.2 Shanghai Bioprofile Business Overview
  238. 6.40.3 Shanghai Bioprofile Serum and Plasma Proteomics Service Revenue, Global Share and Gross Margin (2021-2026)
  239. 6.40.4 Shanghai Bioprofile Serum and Plasma Proteomics Service Product Portfolio
  240. 6.40.5 Shanghai Bioprofile Recent Developments
  241. 6.41 Cosmos Wisdom
  242. 6.42 Olink (Thermo Fisher Scientific)
  243. 6.43 SomaLogic (Illumina)
  244. 6.44 Labcorp
7 North America
  1. 7.1 North America Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  3. 7.3 North America Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  3. 8.3 Europe Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  3. 10.3 South America Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Serum and Plasma Proteomics Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst